20 results
MDRO: Multiple Drug Resistant Organism (Stenehjem E et al. Clin Infect Dis. 2016; 63(10): 1273-1280)

#AntibioticClassificationSchema #Antibiotics
MDRO: Multiple Drug ... #Antibiotics #MDRO
Community Acquired Pneumonia (CAP) Algorithm - Matthew Watto MD @DoctorWatto

#Diagnosis #MDRO #RiskFactors #CAP #Curbsiders
Pneumonia (CAP) Algorithm ... #Diagnosis #MDRO
To improve the usefulness of the serum creatinine concentration as a marker of kidney function, prediction
Renal Disease (MDRD ... However, the MDRD ... Diagnosis #Nephrology #MDRD ... Formulas #Creatinine #Clearance
â–º
Table 1. Equations for estimated glomerular filtration rate (eGFR) in adults based on serum creatinine concentration*.
#Diagnosis
Diagnosis #Nephrology #MDRD ... Formulas #Creatinine #Clearance
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Enterobacteriaceae MDR ... @ABsteward #MDR
Algorithm for the evaluation of pediatric cervical spine injuries #Diagnosis #EM #Peds #Trauma #CSpine #Clear #Clearance
Algorithm for the ... CSpine #Clear #Clearance ... #Decision #Algorithm
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Multidrug-Resistant Organisms (MDRO ... or treated for MDRO ... previous PNA with MDRO
Pseudomonas aeruginosa Resistance to Beta-lactams

Standard Agents: 
Ceftazidime, Cefepime, Piperacillin-Tazobactam, Imipenem, Meropenem

MDR Agents: 
Ceftazidime-Avibactam, CeftoIozane-Tazobactam, Imipenem-Relebactam, Meropenem-Vaborbactam,
, Meropenem MDR
Algorithm for evaluation of cervical spine injuries (Canadian C-spine Imaging Decision Rule) 

#Diagnosis #Management #Trauma #CT
Algorithm for evaluation ... DecisionRule #Cervical #Clearance ... #Algorithm #Ddxof
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
InfectiousDiseases #MDRO